BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15028618)

  • 1. Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue.
    Piletz JE; Wang G; Zhu H
    Ann N Y Acad Sci; 2003 Dec; 1009():392-9. PubMed ID: 15028618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of IRAS/Nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells.
    Sun Z; Chang CH; Ernsberger P
    J Neurochem; 2007 Apr; 101(1):99-108. PubMed ID: 17254010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular effect of imidazoline receptor on alpha(2A)-noradrenergic receptor.
    Chen MJ; Zhu HE; Piletz JE
    Ann N Y Acad Sci; 2003 Dec; 1009():427-38. PubMed ID: 15028622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nischarin as a functional imidazoline (I1) receptor.
    Zhang J; Abdel-Rahman AA
    FEBS Lett; 2006 May; 580(13):3070-4. PubMed ID: 16678176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of agmatine on calcium signal in morphine-dependent CHO cells by activation of IRAS, a candidate for imidazoline I1 receptor.
    Wu N; Su RB; Liu Y; Lu XQ; Zheng JQ; Cong B; Li J
    Eur J Pharmacol; 2006 Oct; 548(1-3):21-8. PubMed ID: 16962578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRAS is an anti-apoptotic protein.
    Dontenwill M; Piletz JE; Chen M; Baldwin J; Pascal G; Ronde P; Dupuy L; Greney H; Takeda K; Bousquetd P
    Ann N Y Acad Sci; 2003 Dec; 1009():400-12. PubMed ID: 15028619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between platelet imidazoline receptor-binding peptides and candidate imidazoline-1 receptor, IRAS.
    Zhu H; Hayes J; Chen M; Baldwin J; Piletz JE
    Ann N Y Acad Sci; 2003 Dec; 1009():439-46. PubMed ID: 15028623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRAS splice variants.
    Piletz JE; Deleersnijder W; Roth BL; Ernsberger P; Zhu H; Ziegler D
    Ann N Y Acad Sci; 2003 Dec; 1009():419-26. PubMed ID: 15028621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein.
    Li F; Wu N; Su RB; Zheng JQ; Xu B; Lu XQ; Cong B; Li J
    J Cell Biochem; 2006 Aug; 98(6):1615-28. PubMed ID: 16598778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of IRAS/nischarin (I
    Keller B; La Harpe R; García-Sevilla JA
    Neurochem Int; 2017 Sep; 108():282-286. PubMed ID: 28461172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization.
    Piletz JE; Ivanov TR; Sharp JD; Ernsberger P; Chang CH; Pickard RT; Gold G; Roth B; Zhu H; Jones JC; Baldwin J; Reis DJ
    DNA Cell Biol; 2000 Jun; 19(6):319-29. PubMed ID: 10882231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of PRR-containing receptors on scaffolds: a model for imidazoline I(1)-receptor action.
    Musgrave IF; Dehle FC; Piletz J
    Ann N Y Acad Sci; 2003 Dec; 1009():413-8. PubMed ID: 15028620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence.
    Li F; Wu N; Su R; Chen Y; Lu X; Liu Y; Li J
    Addict Biol; 2012 Mar; 17(2):392-408. PubMed ID: 21967557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Nischarin/imidazoline receptor antisera-selected protein is targeted to the endosomes by a combined action of a PX domain and a coiled-coil region.
    Lim KP; Hong W
    J Biol Chem; 2004 Dec; 279(52):54770-82. PubMed ID: 15475348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence.
    Wu N; Su RB; Xu B; Lu XQ; Liu Y; Zheng JQ; Piletz JE; Li J; Qin BY
    Biochem Pharmacol; 2005 Oct; 70(7):1079-87. PubMed ID: 16112088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Nischarin/IRAS in CNS development, injury and diseases.
    Zheng P; Pan C; Zhou C; Liu B; Wang L; Duan S; Ding Y
    J Adv Res; 2023 Dec; 54():43-57. PubMed ID: 36716956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of agmatine on DAMGO-induced mu-opioid receptor down-regulation and internalization via activation of IRAS, a candidate for imidazoline I(1) receptor.
    Gao Y; Li F; Wu N; Su RB; Liu Y; Lu XQ; Liu Y; Li J
    Eur J Pharmacol; 2008 Dec; 599(1-3):18-23. PubMed ID: 18845140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of IRAS/nischarin and other potential I
    Keller B; García-Sevilla JA
    J Affect Disord; 2017 Jan; 208():646-652. PubMed ID: 27836117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells.
    Dontenwill M; Pascal G; Piletz JE; Chen M; Baldwin J; Rondé P; Dupuy L; Urosevic D; Greney H; Takeda K; Bousquet P
    Cell Death Differ; 2003 Aug; 10(8):933-5. PubMed ID: 12868002
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation and characterization of novel human IRAS monoclonal antibodies.
    Wang B; Liu Y; Shan Y; Yao Z; Liu X; Su R; Sun Q; Cong Y; Li J
    J Biomed Biotechnol; 2009; 2009():973754. PubMed ID: 19672324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.